We are live on !
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.05B
AUM Growth
+$101M
(+11%)
Cap. Flow
+$43.1M
Cap. Flow % of AUM
Cap. Flow %
4.1%
Top 10 Holdings %
Top 10 Hldgs %
42.07%
Holding
771
New
70
Increased
261
Reduced
141
Closed
14
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$6.91M |
| 2 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$3.8M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.88M |
| 4 |
Apple
AAPL
|
+$2.84M |
| 5 |
Microsoft
MSFT
|
+$1.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$2.41M |
| 2 |
Cisco
CSCO
|
+$2.37M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$1.85M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.61M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 68.9% |
| 2 | Technology | 7.69% |
| 3 | Healthcare | 5.34% |
| 4 | Financials | 3.58% |
| 5 | Consumer Discretionary | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
Liberty Media Corporation Series A Common Stock
FWONA
$20.9B
| $1K | ﹤0.01% |
25
| – | – |
2019 Q4
3 quarters
|
|
727
Hewlett Packard
HPE
$73.2B
| $1K | ﹤0.01% |
131
+2
| +2% | +$19 |
2019 Q3
4 quarters
|
|
728
LifeVantage
LFVN
$75.5M
| $1K | ﹤0.01% |
103
| – | – |
2019 Q1
6 quarters
|
|
729
Manhattan Associates
MANH
$13B
| $1K | ﹤0.01% |
12
| – | – |
2019 Q4
3 quarters
|
|
730
Matinas BioPharma
MTNB
$2.32M
| $1K | ﹤0.01% |
2
| – | – |
2019 Q4
3 quarters
|
|
731
Micron Technology
MU
$994B
| $1K | ﹤0.01% |
20
| – | – |
2020 Q2
1 quarter
|
|
732
Resideo Technologies
REZI
$2.5B
| $1K | ﹤0.01% |
+134
| New | +$1.7K |
2020 Q3
0 quarters
|
|
733
The RMR Group
RMR
$313M
| $1K | ﹤0.01% |
28
+1
| +4% | +$29 |
2017 Q3
12 quarters
|
|
734
Synchrony
SYF
$24B
| $1K | ﹤0.01% |
32
| – | – |
2018 Q1
10 quarters
|
|
735
Teradyne
TER
$50.8B
| $1K | ﹤0.01% |
+11
| New | +$933 |
2020 Q3
0 quarters
|
|
736
Under Armour Class C
UA
$1.99B
| $1K | ﹤0.01% |
100
| – | – |
2018 Q1
10 quarters
|
|
737
Under Armour
UAA
$2.04B
| $1K | ﹤0.01% |
100
| – | – |
2018 Q1
10 quarters
|
|
738
Vanguard Morningstar Small-Cap Value ETF
VBR
$36B
| $1K | ﹤0.01% |
11
-26
| -70% | -$2.91K |
2013 Q2
29 quarters
|
|
739
Vanguard Financials ETF
VFH
$13.1B
| $1K | ﹤0.01% |
11
| – | – |
2019 Q1
6 quarters
|
|
740
Viking Therapeutics
VKTX
$3.2B
| $1K | ﹤0.01% |
197
| – | – |
2018 Q3
8 quarters
|
|
741
Verastem
VSTM
$783M
| $1K | ﹤0.01% |
83
| – | – |
2020 Q1
2 quarters
|
|
742
WESCO International
WCC
$16.6B
| $1K | ﹤0.01% |
+14
| New | +$598 |
2020 Q3
0 quarters
|
|
743
State Street Financial Select Sector SPDR ETF
XLF
$51.6B
| $1K | ﹤0.01% |
59
| – | – |
2013 Q2
29 quarters
|
|
744
Dentsply Sirona
XRAY
$1.71B
| $1K | ﹤0.01% |
29
| – | – |
2019 Q1
6 quarters
|
|
|
LGF.B
745
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1K | ﹤0.01% |
+69
| New | +$551 |
2020 Q3
0 quarters
|
|
746
DELISTED
Marathon Oil Corporation
MRO
| $1K | ﹤0.01% |
+200
| New | +$1.06K |
2020 Q3
0 quarters
|
|
|
HCDI
747
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
| $1K | ﹤0.01% |
+10
| New | +$1.14K |
2020 Q3
0 quarters
|
|
|
CLDR
748
DELISTED
Cloudera, Inc.
CLDR
| $1K | ﹤0.01% |
82
| – | – |
2019 Q4
3 quarters
|
|
|
APHA
749
DELISTED
Aphria Inc. Common Shares
APHA
| $1K | ﹤0.01% |
150
| – | – |
2020 Q2
1 quarter
|
|
750
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $1K | ﹤0.01% |
401
+1
| +0.3% | +$3 |
2019 Q4
3 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q3 2020 Portfolio in Review
As of Q3 2020, Capital Analysts LLC held 771 positions worth $1.05B, up 11% from $952M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Capital Analysts LLC deployed $43.1M of net new capital in Q3 2020, opening 70 new positions and adding to 261 existing holdings. Its largest new stake was Fiserv Inc: 14,288 shares worth $1.47M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 69% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Chubb, an estimated $2.41M trimmed.
- Capital Analysts LLC's largest Q3 2020 buy was Fiserv Inc: 14,288 shares worth $1.47M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q3 2020, an estimated $6.91M increase.
- Capital Analysts LLC's biggest Q3 2020 reduction was Chubb, cutting an estimated $2.41M.
- Capital Analysts LLC fully exited State Street SPDR S&P Biotech ETF in Q3 2020, selling an estimated $168K.
- Capital Analysts LLC's ten largest holdings make up 42% of its $1.05B portfolio in Q3 2020.
- Capital Analysts LLC opened 70 new positions and closed 14 in Q3 2020.
- Capital Analysts LLC's portfolio value rose 11% quarter-over-quarter to $1.05B.
Based on Capital Analysts LLC's 13F filing for Q3 2020, filed 12 Nov 2020.